Cell‐level systems biology model to study inflammatory bowel diseases and their treatment options
Abstract To help understand the complex and therapeutically challenging inflammatory bowel diseases (IBDs), we developed a systems biology model of the intestinal immune system that is able to describe main aspects of IBD and different treatment modalities thereof. The model, including key cell type...
Main Authors: | Sabine Stübler, Charlotte Kloft, Wilhelm Huisinga |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.12932 |
Similar Items
-
Index analysis: An approach to understand signal transduction with application to the EGFR signalling pathway.
by: Jane Knöchel, et al.
Published: (2024-02-01) -
Deriving mechanism‐based pharmacodynamic models by reducing quantitative systems pharmacology models: An application to warfarin
by: Undine Falkenhagen, et al.
Published: (2023-04-01) -
Biologic targeting in the treatment of inflammatory bowel diseases
by: Matteo Bosani, et al.
Published: (2009-02-01) -
Evaluation of clinical features, treatment options and complications in patients with inflammatory bowel disease
by: Yavuz Beyazıt, et al.
Published: (2022-07-01) -
An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians’ Perspective
by: Carsten Schmidt, et al.
Published: (2021-04-01)